Global Precision Cancer Tests Market Research Report 2025(Status and Outlook)
Precision cancer tests, also known as molecular diagnostics or genomic profiling tests, are advanced diagnostic tools designed to analyze genetic, genomic, or proteomic alterations in a patient's tumor to guide personalized treatment decisions; these tests identify specific biomarkers?such as mutations, gene fusions, copy number variations, or expression levels?that can indicate susceptibility to targeted therapies, immunotherapies, or clinical trials, thereby moving beyond traditional histopathology to enable more accurate prognostication, therapy selection, and monitoring of treatment response or resistance.
The global Precision Cancer Tests market size was estimated at USD 4850.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Precision Cancer Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Precision Cancer Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Precision Cancer Tests market.
Global Precision Cancer Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Market Segmentation (by Type)
Imaging
In Vitro Diagnostic
Others
Market Segmentation (by Application)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Cancer Tests Market
Overview of the regional outlook of the Precision Cancer Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Precision Cancer Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Precision Cancer Tests market size was estimated at USD 4850.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Precision Cancer Tests market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Precision Cancer Tests market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Precision Cancer Tests market.
Global Precision Cancer Tests Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Market Segmentation (by Type)
Imaging
In Vitro Diagnostic
Others
Market Segmentation (by Application)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Precision Cancer Tests Market
Overview of the regional outlook of the Precision Cancer Tests Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Precision Cancer Tests Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Precision Cancer Tests, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Precision Cancer Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Tests Segment by Type
1.2.2 Precision Cancer Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRECISION CANCER TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Cancer Tests Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Precision Cancer Tests Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRECISION CANCER TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Cancer Tests Product Life Cycle
3.3 Global Precision Cancer Tests Sales by Manufacturers (2020-2025)
3.4 Global Precision Cancer Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Cancer Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Precision Cancer Tests Market Competitive Situation and Trends
3.8.1 Precision Cancer Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Cancer Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION CANCER TESTS INDUSTRY CHAIN ANALYSIS
4.1 Precision Cancer Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION CANCER TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Cancer Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Precision Cancer Tests Market
5.7 ESG Ratings of Leading Companies
6 PRECISION CANCER TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Tests Sales Market Share by Type (2020-2025)
6.3 Global Precision Cancer Tests Market Size Market Share by Type (2020-2025)
6.4 Global Precision Cancer Tests Price by Type (2020-2025)
7 PRECISION CANCER TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Tests Market Sales by Application (2020-2025)
7.3 Global Precision Cancer Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
8 PRECISION CANCER TESTS MARKET SALES BY REGION
8.1 Global Precision Cancer Tests Sales by Region
8.1.1 Global Precision Cancer Tests Sales by Region
8.1.2 Global Precision Cancer Tests Sales Market Share by Region
8.2 Global Precision Cancer Tests Market Size by Region
8.2.1 Global Precision Cancer Tests Market Size by Region
8.2.2 Global Precision Cancer Tests Market Size Market Share by Region
8.3 North America
8.3.1 North America Precision Cancer Tests Sales by Country
8.3.2 North America Precision Cancer Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Precision Cancer Tests Sales by Country
8.4.2 Europe Precision Cancer Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Precision Cancer Tests Sales by Region
8.5.2 Asia Pacific Precision Cancer Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Precision Cancer Tests Sales by Country
8.6.2 South America Precision Cancer Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Precision Cancer Tests Sales by Region
8.7.2 Middle East and Africa Precision Cancer Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRECISION CANCER TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Precision Cancer Tests by Region(2020-2025)
9.2 Global Precision Cancer Tests Revenue Market Share by Region (2020-2025)
9.3 Global Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Precision Cancer Tests Production
9.4.1 North America Precision Cancer Tests Production Growth Rate (2020-2025)
9.4.2 North America Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Precision Cancer Tests Production
9.5.1 Europe Precision Cancer Tests Production Growth Rate (2020-2025)
9.5.2 Europe Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Precision Cancer Tests Production (2020-2025)
9.6.1 Japan Precision Cancer Tests Production Growth Rate (2020-2025)
9.6.2 Japan Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Precision Cancer Tests Production (2020-2025)
9.7.1 China Precision Cancer Tests Production Growth Rate (2020-2025)
9.7.2 China Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Precision Cancer Tests Product Overview
10.1.3 Abbott Precision Cancer Tests Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 BD
10.2.1 BD Basic Information
10.2.2 BD Precision Cancer Tests Product Overview
10.2.3 BD Precision Cancer Tests Product Market Performance
10.2.4 BD Business Overview
10.2.5 BD SWOT Analysis
10.2.6 BD Recent Developments
10.3 Bio-Rad
10.3.1 Bio-Rad Basic Information
10.3.2 Bio-Rad Precision Cancer Tests Product Overview
10.3.3 Bio-Rad Precision Cancer Tests Product Market Performance
10.3.4 Bio-Rad Business Overview
10.3.5 Bio-Rad SWOT Analysis
10.3.6 Bio-Rad Recent Developments
10.4 Cynvenio Biosystems
10.4.1 Cynvenio Biosystems Basic Information
10.4.2 Cynvenio Biosystems Precision Cancer Tests Product Overview
10.4.3 Cynvenio Biosystems Precision Cancer Tests Product Market Performance
10.4.4 Cynvenio Biosystems Business Overview
10.4.5 Cynvenio Biosystems Recent Developments
10.5 Foundation Medicine
10.5.1 Foundation Medicine Basic Information
10.5.2 Foundation Medicine Precision Cancer Tests Product Overview
10.5.3 Foundation Medicine Precision Cancer Tests Product Market Performance
10.5.4 Foundation Medicine Business Overview
10.5.5 Foundation Medicine Recent Developments
10.6 Genomic Health
10.6.1 Genomic Health Basic Information
10.6.2 Genomic Health Precision Cancer Tests Product Overview
10.6.3 Genomic Health Precision Cancer Tests Product Market Performance
10.6.4 Genomic Health Business Overview
10.6.5 Genomic Health Recent Developments
10.7 Illumina
10.7.1 Illumina Basic Information
10.7.2 Illumina Precision Cancer Tests Product Overview
10.7.3 Illumina Precision Cancer Tests Product Market Performance
10.7.4 Illumina Business Overview
10.7.5 Illumina Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Basic Information
10.8.2 Myriad Genetics Precision Cancer Tests Product Overview
10.8.3 Myriad Genetics Precision Cancer Tests Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 NanoString Technologies
10.9.1 NanoString Technologies Basic Information
10.9.2 NanoString Technologies Precision Cancer Tests Product Overview
10.9.3 NanoString Technologies Precision Cancer Tests Product Market Performance
10.9.4 NanoString Technologies Business Overview
10.9.5 NanoString Technologies Recent Developments
10.10 QIAGEN
10.10.1 QIAGEN Basic Information
10.10.2 QIAGEN Precision Cancer Tests Product Overview
10.10.3 QIAGEN Precision Cancer Tests Product Market Performance
10.10.4 QIAGEN Business Overview
10.10.5 QIAGEN Recent Developments
10.11 Randox Laboratories
10.11.1 Randox Laboratories Basic Information
10.11.2 Randox Laboratories Precision Cancer Tests Product Overview
10.11.3 Randox Laboratories Precision Cancer Tests Product Market Performance
10.11.4 Randox Laboratories Business Overview
10.11.5 Randox Laboratories Recent Developments
10.12 Roche
10.12.1 Roche Basic Information
10.12.2 Roche Precision Cancer Tests Product Overview
10.12.3 Roche Precision Cancer Tests Product Market Performance
10.12.4 Roche Business Overview
10.12.5 Roche Recent Developments
10.13 Philips
10.13.1 Philips Basic Information
10.13.2 Philips Precision Cancer Tests Product Overview
10.13.3 Philips Precision Cancer Tests Product Market Performance
10.13.4 Philips Business Overview
10.13.5 Philips Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Basic Information
10.14.2 Thermo Fisher Scientific Precision Cancer Tests Product Overview
10.14.3 Thermo Fisher Scientific Precision Cancer Tests Product Market Performance
10.14.4 Thermo Fisher Scientific Business Overview
10.14.5 Thermo Fisher Scientific Recent Developments
11 PRECISION CANCER TESTS MARKET FORECAST BY REGION
11.1 Global Precision Cancer Tests Market Size Forecast
11.2 Global Precision Cancer Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Precision Cancer Tests Market Size Forecast by Country
11.2.3 Asia Pacific Precision Cancer Tests Market Size Forecast by Region
11.2.4 South America Precision Cancer Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Precision Cancer Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Precision Cancer Tests Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Precision Cancer Tests by Type (2026-2033)
12.1.2 Global Precision Cancer Tests Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Precision Cancer Tests by Type (2026-2033)
12.2 Global Precision Cancer Tests Market Forecast by Application (2026-2033)
12.2.1 Global Precision Cancer Tests Sales (K Units) Forecast by Application
12.2.2 Global Precision Cancer Tests Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Precision Cancer Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Tests Segment by Type
1.2.2 Precision Cancer Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRECISION CANCER TESTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Precision Cancer Tests Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Precision Cancer Tests Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRECISION CANCER TESTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Precision Cancer Tests Product Life Cycle
3.3 Global Precision Cancer Tests Sales by Manufacturers (2020-2025)
3.4 Global Precision Cancer Tests Revenue Market Share by Manufacturers (2020-2025)
3.5 Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Precision Cancer Tests Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Precision Cancer Tests Market Competitive Situation and Trends
3.8.1 Precision Cancer Tests Market Concentration Rate
3.8.2 Global 5 and 10 Largest Precision Cancer Tests Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PRECISION CANCER TESTS INDUSTRY CHAIN ANALYSIS
4.1 Precision Cancer Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRECISION CANCER TESTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Precision Cancer Tests Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Precision Cancer Tests Market
5.7 ESG Ratings of Leading Companies
6 PRECISION CANCER TESTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Tests Sales Market Share by Type (2020-2025)
6.3 Global Precision Cancer Tests Market Size Market Share by Type (2020-2025)
6.4 Global Precision Cancer Tests Price by Type (2020-2025)
7 PRECISION CANCER TESTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Tests Market Sales by Application (2020-2025)
7.3 Global Precision Cancer Tests Market Size (M USD) by Application (2020-2025)
7.4 Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
8 PRECISION CANCER TESTS MARKET SALES BY REGION
8.1 Global Precision Cancer Tests Sales by Region
8.1.1 Global Precision Cancer Tests Sales by Region
8.1.2 Global Precision Cancer Tests Sales Market Share by Region
8.2 Global Precision Cancer Tests Market Size by Region
8.2.1 Global Precision Cancer Tests Market Size by Region
8.2.2 Global Precision Cancer Tests Market Size Market Share by Region
8.3 North America
8.3.1 North America Precision Cancer Tests Sales by Country
8.3.2 North America Precision Cancer Tests Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Precision Cancer Tests Sales by Country
8.4.2 Europe Precision Cancer Tests Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Precision Cancer Tests Sales by Region
8.5.2 Asia Pacific Precision Cancer Tests Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Precision Cancer Tests Sales by Country
8.6.2 South America Precision Cancer Tests Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Precision Cancer Tests Sales by Region
8.7.2 Middle East and Africa Precision Cancer Tests Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PRECISION CANCER TESTS MARKET PRODUCTION BY REGION
9.1 Global Production of Precision Cancer Tests by Region(2020-2025)
9.2 Global Precision Cancer Tests Revenue Market Share by Region (2020-2025)
9.3 Global Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Precision Cancer Tests Production
9.4.1 North America Precision Cancer Tests Production Growth Rate (2020-2025)
9.4.2 North America Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Precision Cancer Tests Production
9.5.1 Europe Precision Cancer Tests Production Growth Rate (2020-2025)
9.5.2 Europe Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Precision Cancer Tests Production (2020-2025)
9.6.1 Japan Precision Cancer Tests Production Growth Rate (2020-2025)
9.6.2 Japan Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Precision Cancer Tests Production (2020-2025)
9.7.1 China Precision Cancer Tests Production Growth Rate (2020-2025)
9.7.2 China Precision Cancer Tests Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Precision Cancer Tests Product Overview
10.1.3 Abbott Precision Cancer Tests Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 BD
10.2.1 BD Basic Information
10.2.2 BD Precision Cancer Tests Product Overview
10.2.3 BD Precision Cancer Tests Product Market Performance
10.2.4 BD Business Overview
10.2.5 BD SWOT Analysis
10.2.6 BD Recent Developments
10.3 Bio-Rad
10.3.1 Bio-Rad Basic Information
10.3.2 Bio-Rad Precision Cancer Tests Product Overview
10.3.3 Bio-Rad Precision Cancer Tests Product Market Performance
10.3.4 Bio-Rad Business Overview
10.3.5 Bio-Rad SWOT Analysis
10.3.6 Bio-Rad Recent Developments
10.4 Cynvenio Biosystems
10.4.1 Cynvenio Biosystems Basic Information
10.4.2 Cynvenio Biosystems Precision Cancer Tests Product Overview
10.4.3 Cynvenio Biosystems Precision Cancer Tests Product Market Performance
10.4.4 Cynvenio Biosystems Business Overview
10.4.5 Cynvenio Biosystems Recent Developments
10.5 Foundation Medicine
10.5.1 Foundation Medicine Basic Information
10.5.2 Foundation Medicine Precision Cancer Tests Product Overview
10.5.3 Foundation Medicine Precision Cancer Tests Product Market Performance
10.5.4 Foundation Medicine Business Overview
10.5.5 Foundation Medicine Recent Developments
10.6 Genomic Health
10.6.1 Genomic Health Basic Information
10.6.2 Genomic Health Precision Cancer Tests Product Overview
10.6.3 Genomic Health Precision Cancer Tests Product Market Performance
10.6.4 Genomic Health Business Overview
10.6.5 Genomic Health Recent Developments
10.7 Illumina
10.7.1 Illumina Basic Information
10.7.2 Illumina Precision Cancer Tests Product Overview
10.7.3 Illumina Precision Cancer Tests Product Market Performance
10.7.4 Illumina Business Overview
10.7.5 Illumina Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Basic Information
10.8.2 Myriad Genetics Precision Cancer Tests Product Overview
10.8.3 Myriad Genetics Precision Cancer Tests Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 NanoString Technologies
10.9.1 NanoString Technologies Basic Information
10.9.2 NanoString Technologies Precision Cancer Tests Product Overview
10.9.3 NanoString Technologies Precision Cancer Tests Product Market Performance
10.9.4 NanoString Technologies Business Overview
10.9.5 NanoString Technologies Recent Developments
10.10 QIAGEN
10.10.1 QIAGEN Basic Information
10.10.2 QIAGEN Precision Cancer Tests Product Overview
10.10.3 QIAGEN Precision Cancer Tests Product Market Performance
10.10.4 QIAGEN Business Overview
10.10.5 QIAGEN Recent Developments
10.11 Randox Laboratories
10.11.1 Randox Laboratories Basic Information
10.11.2 Randox Laboratories Precision Cancer Tests Product Overview
10.11.3 Randox Laboratories Precision Cancer Tests Product Market Performance
10.11.4 Randox Laboratories Business Overview
10.11.5 Randox Laboratories Recent Developments
10.12 Roche
10.12.1 Roche Basic Information
10.12.2 Roche Precision Cancer Tests Product Overview
10.12.3 Roche Precision Cancer Tests Product Market Performance
10.12.4 Roche Business Overview
10.12.5 Roche Recent Developments
10.13 Philips
10.13.1 Philips Basic Information
10.13.2 Philips Precision Cancer Tests Product Overview
10.13.3 Philips Precision Cancer Tests Product Market Performance
10.13.4 Philips Business Overview
10.13.5 Philips Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Basic Information
10.14.2 Thermo Fisher Scientific Precision Cancer Tests Product Overview
10.14.3 Thermo Fisher Scientific Precision Cancer Tests Product Market Performance
10.14.4 Thermo Fisher Scientific Business Overview
10.14.5 Thermo Fisher Scientific Recent Developments
11 PRECISION CANCER TESTS MARKET FORECAST BY REGION
11.1 Global Precision Cancer Tests Market Size Forecast
11.2 Global Precision Cancer Tests Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Precision Cancer Tests Market Size Forecast by Country
11.2.3 Asia Pacific Precision Cancer Tests Market Size Forecast by Region
11.2.4 South America Precision Cancer Tests Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Precision Cancer Tests by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Precision Cancer Tests Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Precision Cancer Tests by Type (2026-2033)
12.1.2 Global Precision Cancer Tests Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Precision Cancer Tests by Type (2026-2033)
12.2 Global Precision Cancer Tests Market Forecast by Application (2026-2033)
12.2.1 Global Precision Cancer Tests Sales (K Units) Forecast by Application
12.2.2 Global Precision Cancer Tests Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Precision Cancer Tests Market Size Comparison by Region (M USD)
Table 5. Global Precision Cancer Tests Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Precision Cancer Tests Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Precision Cancer Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Precision Cancer Tests Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2024)
Table 10. Global Market Precision Cancer Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Precision Cancer Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Precision Cancer Tests Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Precision Cancer Tests Sales by Type (K Units)
Table 26. Global Precision Cancer Tests Market Size by Type (M USD)
Table 27. Global Precision Cancer Tests Sales (K Units) by Type (2020-2025)
Table 28. Global Precision Cancer Tests Sales Market Share by Type (2020-2025)
Table 29. Global Precision Cancer Tests Market Size (M USD) by Type (2020-2025)
Table 30. Global Precision Cancer Tests Market Size Share by Type (2020-2025)
Table 31. Global Precision Cancer Tests Price (USD/Unit) by Type (2020-2025)
Table 32. Global Precision Cancer Tests Sales (K Units) by Application
Table 33. Global Precision Cancer Tests Market Size by Application
Table 34. Global Precision Cancer Tests Sales by Application (2020-2025) & (K Units)
Table 35. Global Precision Cancer Tests Sales Market Share by Application (2020-2025)
Table 36. Global Precision Cancer Tests Market Size by Application (2020-2025) & (M USD)
Table 37. Global Precision Cancer Tests Market Share by Application (2020-2025)
Table 38. Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
Table 39. Global Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 40. Global Precision Cancer Tests Sales Market Share by Region (2020-2025)
Table 41. Global Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 42. Global Precision Cancer Tests Market Size Market Share by Region (2020-2025)
Table 43. North America Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 44. North America Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 46. Europe Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 49. South America Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 50. South America Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 53. Global Precision Cancer Tests Production (K Units) by Region(2020-2025)
Table 54. Global Precision Cancer Tests Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Precision Cancer Tests Revenue Market Share by Region (2020-2025)
Table 56. Global Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Basic Information
Table 62. Abbott Precision Cancer Tests Product Overview
Table 63. Abbott Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Business Overview
Table 65. Abbott SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. BD Basic Information
Table 68. BD Precision Cancer Tests Product Overview
Table 69. BD Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. BD Business Overview
Table 71. BD SWOT Analysis
Table 72. BD Recent Developments
Table 73. Bio-Rad Basic Information
Table 74. Bio-Rad Precision Cancer Tests Product Overview
Table 75. Bio-Rad Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad SWOT Analysis
Table 78. Bio-Rad Recent Developments
Table 79. Cynvenio Biosystems Basic Information
Table 80. Cynvenio Biosystems Precision Cancer Tests Product Overview
Table 81. Cynvenio Biosystems Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Cynvenio Biosystems Business Overview
Table 83. Cynvenio Biosystems Recent Developments
Table 84. Foundation Medicine Basic Information
Table 85. Foundation Medicine Precision Cancer Tests Product Overview
Table 86. Foundation Medicine Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Foundation Medicine Business Overview
Table 88. Foundation Medicine Recent Developments
Table 89. Genomic Health Basic Information
Table 90. Genomic Health Precision Cancer Tests Product Overview
Table 91. Genomic Health Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Genomic Health Business Overview
Table 93. Genomic Health Recent Developments
Table 94. Illumina Basic Information
Table 95. Illumina Precision Cancer Tests Product Overview
Table 96. Illumina Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Illumina Business Overview
Table 98. Illumina Recent Developments
Table 99. Myriad Genetics Basic Information
Table 100. Myriad Genetics Precision Cancer Tests Product Overview
Table 101. Myriad Genetics Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. NanoString Technologies Basic Information
Table 105. NanoString Technologies Precision Cancer Tests Product Overview
Table 106. NanoString Technologies Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. NanoString Technologies Business Overview
Table 108. NanoString Technologies Recent Developments
Table 109. QIAGEN Basic Information
Table 110. QIAGEN Precision Cancer Tests Product Overview
Table 111. QIAGEN Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. QIAGEN Business Overview
Table 113. QIAGEN Recent Developments
Table 114. Randox Laboratories Basic Information
Table 115. Randox Laboratories Precision Cancer Tests Product Overview
Table 116. Randox Laboratories Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Randox Laboratories Business Overview
Table 118. Randox Laboratories Recent Developments
Table 119. Roche Basic Information
Table 120. Roche Precision Cancer Tests Product Overview
Table 121. Roche Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Roche Business Overview
Table 123. Roche Recent Developments
Table 124. Philips Basic Information
Table 125. Philips Precision Cancer Tests Product Overview
Table 126. Philips Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Philips Business Overview
Table 128. Philips Recent Developments
Table 129. Thermo Fisher Scientific Basic Information
Table 130. Thermo Fisher Scientific Precision Cancer Tests Product Overview
Table 131. Thermo Fisher Scientific Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Recent Developments
Table 134. Global Precision Cancer Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Precision Cancer Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Precision Cancer Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Precision Cancer Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Precision Cancer Tests Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Precision Cancer Tests Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Precision Cancer Tests Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Precision Cancer Tests Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Precision Cancer Tests Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Precision Cancer Tests Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Precision Cancer Tests Market Size Comparison by Region (M USD)
Table 5. Global Precision Cancer Tests Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Precision Cancer Tests Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Precision Cancer Tests Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Precision Cancer Tests Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2024)
Table 10. Global Market Precision Cancer Tests Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Precision Cancer Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Precision Cancer Tests Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Precision Cancer Tests Sales by Type (K Units)
Table 26. Global Precision Cancer Tests Market Size by Type (M USD)
Table 27. Global Precision Cancer Tests Sales (K Units) by Type (2020-2025)
Table 28. Global Precision Cancer Tests Sales Market Share by Type (2020-2025)
Table 29. Global Precision Cancer Tests Market Size (M USD) by Type (2020-2025)
Table 30. Global Precision Cancer Tests Market Size Share by Type (2020-2025)
Table 31. Global Precision Cancer Tests Price (USD/Unit) by Type (2020-2025)
Table 32. Global Precision Cancer Tests Sales (K Units) by Application
Table 33. Global Precision Cancer Tests Market Size by Application
Table 34. Global Precision Cancer Tests Sales by Application (2020-2025) & (K Units)
Table 35. Global Precision Cancer Tests Sales Market Share by Application (2020-2025)
Table 36. Global Precision Cancer Tests Market Size by Application (2020-2025) & (M USD)
Table 37. Global Precision Cancer Tests Market Share by Application (2020-2025)
Table 38. Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
Table 39. Global Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 40. Global Precision Cancer Tests Sales Market Share by Region (2020-2025)
Table 41. Global Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 42. Global Precision Cancer Tests Market Size Market Share by Region (2020-2025)
Table 43. North America Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 44. North America Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 46. Europe Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 49. South America Precision Cancer Tests Sales by Country (2020-2025) & (K Units)
Table 50. South America Precision Cancer Tests Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Precision Cancer Tests Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Precision Cancer Tests Market Size by Region (2020-2025) & (M USD)
Table 53. Global Precision Cancer Tests Production (K Units) by Region(2020-2025)
Table 54. Global Precision Cancer Tests Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Precision Cancer Tests Revenue Market Share by Region (2020-2025)
Table 56. Global Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Precision Cancer Tests Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Basic Information
Table 62. Abbott Precision Cancer Tests Product Overview
Table 63. Abbott Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Business Overview
Table 65. Abbott SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. BD Basic Information
Table 68. BD Precision Cancer Tests Product Overview
Table 69. BD Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. BD Business Overview
Table 71. BD SWOT Analysis
Table 72. BD Recent Developments
Table 73. Bio-Rad Basic Information
Table 74. Bio-Rad Precision Cancer Tests Product Overview
Table 75. Bio-Rad Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad SWOT Analysis
Table 78. Bio-Rad Recent Developments
Table 79. Cynvenio Biosystems Basic Information
Table 80. Cynvenio Biosystems Precision Cancer Tests Product Overview
Table 81. Cynvenio Biosystems Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Cynvenio Biosystems Business Overview
Table 83. Cynvenio Biosystems Recent Developments
Table 84. Foundation Medicine Basic Information
Table 85. Foundation Medicine Precision Cancer Tests Product Overview
Table 86. Foundation Medicine Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Foundation Medicine Business Overview
Table 88. Foundation Medicine Recent Developments
Table 89. Genomic Health Basic Information
Table 90. Genomic Health Precision Cancer Tests Product Overview
Table 91. Genomic Health Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Genomic Health Business Overview
Table 93. Genomic Health Recent Developments
Table 94. Illumina Basic Information
Table 95. Illumina Precision Cancer Tests Product Overview
Table 96. Illumina Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Illumina Business Overview
Table 98. Illumina Recent Developments
Table 99. Myriad Genetics Basic Information
Table 100. Myriad Genetics Precision Cancer Tests Product Overview
Table 101. Myriad Genetics Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Recent Developments
Table 104. NanoString Technologies Basic Information
Table 105. NanoString Technologies Precision Cancer Tests Product Overview
Table 106. NanoString Technologies Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. NanoString Technologies Business Overview
Table 108. NanoString Technologies Recent Developments
Table 109. QIAGEN Basic Information
Table 110. QIAGEN Precision Cancer Tests Product Overview
Table 111. QIAGEN Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. QIAGEN Business Overview
Table 113. QIAGEN Recent Developments
Table 114. Randox Laboratories Basic Information
Table 115. Randox Laboratories Precision Cancer Tests Product Overview
Table 116. Randox Laboratories Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Randox Laboratories Business Overview
Table 118. Randox Laboratories Recent Developments
Table 119. Roche Basic Information
Table 120. Roche Precision Cancer Tests Product Overview
Table 121. Roche Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Roche Business Overview
Table 123. Roche Recent Developments
Table 124. Philips Basic Information
Table 125. Philips Precision Cancer Tests Product Overview
Table 126. Philips Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Philips Business Overview
Table 128. Philips Recent Developments
Table 129. Thermo Fisher Scientific Basic Information
Table 130. Thermo Fisher Scientific Precision Cancer Tests Product Overview
Table 131. Thermo Fisher Scientific Precision Cancer Tests Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Recent Developments
Table 134. Global Precision Cancer Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Precision Cancer Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Precision Cancer Tests Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Precision Cancer Tests Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Precision Cancer Tests Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Precision Cancer Tests Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Precision Cancer Tests Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Precision Cancer Tests Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Precision Cancer Tests Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Precision Cancer Tests Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Precision Cancer Tests Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Precision Cancer Tests Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Precision Cancer Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Cancer Tests Market Size (M USD), 2024-2033
Figure 5. Global Precision Cancer Tests Market Size (M USD) (2020-2033)
Figure 6. Global Precision Cancer Tests Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Cancer Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Cancer Tests Product Life Cycle
Figure 13. Precision Cancer Tests Sales Share by Manufacturers in 2024
Figure 14. Global Precision Cancer Tests Revenue Share by Manufacturers in 2024
Figure 15. Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Precision Cancer Tests Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Cancer Tests Revenue in 2024
Figure 18. Industry Chain Map of Precision Cancer Tests
Figure 19. Global Precision Cancer Tests Market PEST Analysis
Figure 20. Global Precision Cancer Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Precision Cancer Tests Market Share by Type
Figure 27. Sales Market Share of Precision Cancer Tests by Type (2020-2025)
Figure 28. Sales Market Share of Precision Cancer Tests by Type in 2024
Figure 29. Market Size Share of Precision Cancer Tests by Type (2020-2025)
Figure 30. Market Size Share of Precision Cancer Tests by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Precision Cancer Tests Market Share by Application
Figure 33. Global Precision Cancer Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Precision Cancer Tests Sales Market Share by Application in 2024
Figure 35. Global Precision Cancer Tests Market Share by Application (2020-2025)
Figure 36. Global Precision Cancer Tests Market Share by Application in 2024
Figure 37. Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Precision Cancer Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Precision Cancer Tests Market Size Market Share by Region (2020-2025)
Figure 40. North America Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Precision Cancer Tests Sales Market Share by Country in 2024
Figure 43. North America Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 45. U.S. Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Precision Cancer Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Precision Cancer Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Precision Cancer Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Precision Cancer Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Precision Cancer Tests Sales Market Share by Country in 2024
Figure 53. Europe Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 55. Germany Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Precision Cancer Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Precision Cancer Tests Market Size Market Share by Region in 2024
Figure 68. China Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 79. South America Precision Cancer Tests Sales Market Share by Country in 2024
Figure 80. South America Precision Cancer Tests Market Size and Growth Rate (M USD)
Figure 81. South America Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 82. Brazil Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Precision Cancer Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Precision Cancer Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Precision Cancer Tests Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Precision Cancer Tests Production Market Share by Region (2020-2025)
Figure 103. North America Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Precision Cancer Tests Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Precision Cancer Tests Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Precision Cancer Tests Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Precision Cancer Tests Market Share Forecast by Type (2026-2033)
Figure 111. Global Precision Cancer Tests Sales Forecast by Application (2026-2033)
Figure 112. Global Precision Cancer Tests Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Precision Cancer Tests
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Precision Cancer Tests Market Size (M USD), 2024-2033
Figure 5. Global Precision Cancer Tests Market Size (M USD) (2020-2033)
Figure 6. Global Precision Cancer Tests Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Precision Cancer Tests Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Precision Cancer Tests Product Life Cycle
Figure 13. Precision Cancer Tests Sales Share by Manufacturers in 2024
Figure 14. Global Precision Cancer Tests Revenue Share by Manufacturers in 2024
Figure 15. Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Precision Cancer Tests Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Precision Cancer Tests Revenue in 2024
Figure 18. Industry Chain Map of Precision Cancer Tests
Figure 19. Global Precision Cancer Tests Market PEST Analysis
Figure 20. Global Precision Cancer Tests Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Precision Cancer Tests Market Share by Type
Figure 27. Sales Market Share of Precision Cancer Tests by Type (2020-2025)
Figure 28. Sales Market Share of Precision Cancer Tests by Type in 2024
Figure 29. Market Size Share of Precision Cancer Tests by Type (2020-2025)
Figure 30. Market Size Share of Precision Cancer Tests by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Precision Cancer Tests Market Share by Application
Figure 33. Global Precision Cancer Tests Sales Market Share by Application (2020-2025)
Figure 34. Global Precision Cancer Tests Sales Market Share by Application in 2024
Figure 35. Global Precision Cancer Tests Market Share by Application (2020-2025)
Figure 36. Global Precision Cancer Tests Market Share by Application in 2024
Figure 37. Global Precision Cancer Tests Sales Growth Rate by Application (2020-2025)
Figure 38. Global Precision Cancer Tests Sales Market Share by Region (2020-2025)
Figure 39. Global Precision Cancer Tests Market Size Market Share by Region (2020-2025)
Figure 40. North America Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Precision Cancer Tests Sales Market Share by Country in 2024
Figure 43. North America Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 45. U.S. Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Precision Cancer Tests Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Precision Cancer Tests Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Precision Cancer Tests Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Precision Cancer Tests Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Precision Cancer Tests Sales Market Share by Country in 2024
Figure 53. Europe Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 55. Germany Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Precision Cancer Tests Sales Market Share by Region in 2024
Figure 67. Asia Pacific Precision Cancer Tests Market Size Market Share by Region in 2024
Figure 68. China Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 79. South America Precision Cancer Tests Sales Market Share by Country in 2024
Figure 80. South America Precision Cancer Tests Market Size and Growth Rate (M USD)
Figure 81. South America Precision Cancer Tests Market Size Market Share by Country in 2024
Figure 82. Brazil Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Precision Cancer Tests Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Precision Cancer Tests Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Precision Cancer Tests Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Precision Cancer Tests Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Precision Cancer Tests Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Precision Cancer Tests Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Precision Cancer Tests Production Market Share by Region (2020-2025)
Figure 103. North America Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 106. China Precision Cancer Tests Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Precision Cancer Tests Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Precision Cancer Tests Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Precision Cancer Tests Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Precision Cancer Tests Market Share Forecast by Type (2026-2033)
Figure 111. Global Precision Cancer Tests Sales Forecast by Application (2026-2033)
Figure 112. Global Precision Cancer Tests Market Share Forecast by Application (2026-2033)
